The Central Drugs Standard Control Organisation (CDSCO) on May 16, 2023, issued a list of Drugs, Medical Devices, and Cosmetics, declaring them as Not of Standard Quality/Spurious/Adulterated/Misbranded for the Month of April 2023.
The Table with the Name of Drugs/Medical Devices/Cosmetics, Batch No./Date of Manufacture/Date of Expiry/ Manufacture, and Reason for Failure, drawn by and from have been inserted.
A few Drugs/medical devices/cosmetics are as follows: -
• Losartan Tablets I.P. 25 mg
• Omitan – 20 (Olmesartan Medoxomil Tablets I.P.)
• Paracetamol Tablets I.P. 500 mg
• Metopal – 50 XL (Metoprolol Succinate Extended Release Tablets IP)
• Paracetamol Tablets I.P. 500 mg
• Astrazol (Zoledronic Acid Injection IP 4 mg)
• Astrizo-2.5 Tablets (Letrozole Tablets I.P. 2.5 mg)
